Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

Annals of Oncology(2021)10.1016/j.annonc.2021.02.024Source: DataRank Database

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium is a research paper published in Annals of Oncology (2021). On theSindex it has a DataRank of 6.8. It has been cited 328 times, with 100 citing works in its 1-hop citation network.

N/A

6.8DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access328 citations · 100 citing works in its network

Free full text

Cite:

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT04354701

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (24 grants)Impact (FWCI 24.16)OA: hybridTopics (19)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 13%Citation Network 87%

Base Score Contribution

0.869

From this paper's citation signal

Citation Network Contribution

6.0

From 100 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 100 citers.

Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer
Cancer Cell202165 citations10 referencesContributes 0.419
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer
Cancer Cell202162 citations13 referencesContributes 0.319
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
JAMA Oncology202225 citations14 referencesContributes 0.233
Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID‐19: disease control as an important factor relative to recent chemotherapy or anti‐CD20 therapy
British Journal of Haematology202138 citations17 referencesContributes 0.216
Monkeypox has devastated the world; should we prepare for the outbreak of a new pandemic?
Annals of Medicine and Surgery202223 citations17 referencesContributes 0.187

Authors (100)

Ali Raza Khaki ORCID,Trisha M. Wise‐Draper ORCID,Benjamin French ORCID,Conor Hennessy ORCID,Chih–Yuan Hsu ORCID

Live enrichment

PubMed:33746047 OpenAlex:https://openalex.org/W3136076419

National Cancer Institute

Grant: U01 CA231840

National Cancer Institute

Grant: P30CA054174

National Cancer Institute

Grant: 2UG1CA189859-06

National Cancer Institute

Grant: P30 CA068485

National Cancer Institute

Grant: P30CA015704

National Cancer Institute

Grant: P30 CA177558

National Cancer Institute

Grant: P30CA023100

National Cancer Institute

Grant: P30 CA196521

National Cancer Institute

Grant: T32CA236621

National Cancer Institute

Grant: 5P30CA056036-20

National Cancer Institute

Grant: 1P30CA240139-01

National Cancer Institute

Grant: P30 CA046592

National Cancer Institute

Grant: P30CA013696

National Cancer Institute

Grant: T32CA009515

National Cancer Institute

Grant: P30 CA013330

National Cancer Institute

Grant: P30CA046934

NIH

Grant: UG1 CA189974

NIH

Grant: 2UL1TR001425-05A1

NIH

Grant: P30 CA168524

NIH

Grant: UL1TR001873

NIH

Grant: 2UG1CA190140-06

NIH

Grant: P30 CA016058

Korean Foundation for Cancer Research

Grant: MRSG-16-152-01

American Cancer Society

Grant: MRSG-16-152-01-CCE

FWCI

24.16

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttp://www.annalsofoncology.org/article/S0923753421008747/pdf

publisherhttp://www.annalsofoncology.org/article/S0923753421008747/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0923753421008747?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0923753421008747?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.annonc.2021.02.024

Fields of Study

COVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19

MeSH Terms

COVID-19SARS-CoV-2COVID-19 TestingAgedFemaleHumansMaleNeoplasmsPandemics

Keywords

MedicineInternal medicineCancerAbsolute neutrophil countLung cancerChemotherapyNeutropenia

Sustainable Development Goals

SDG 0: Good health and well-being

Related Papers (10)

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

N/A

11.9DataRank · unranked

The Lancet(2020)

co-cited

10.1016/s0140-6736(20)31187-9

SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63

N/A

8.9DataRank · unranked

Journal of Clinical Investigation(2021)

co-cited

10.1172/jci149335

Correlates of protection against SARS-CoV-2 in rhesus macaques

N/A

18.5DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-03041-6

Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

N/A

12.3DataRank · unranked

Science(2020)

co-cited

10.1126/science.abc6261

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

N/A

13.4DataRank · unranked

Blood(2020)

co-cited

10.1182/blood.2020006965

Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak

N/A

1.1DataRank · unranked

Cancer Discovery(2020)

co-cited

10.1158/2159-8290.cd-20-0422

SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness

N/A

12.4DataRank · unranked

Nature(2020)

co-cited

10.1038/s41586-020-2622-0

The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

N/A

0.972DataRank · unranked

The Lancet. Gastroenterology & hepatology(2020)

co-cited

10.1016/s2468-1253(20)30007-8

The National COVID Cohort Collaborative (N3C): Rationale, design, infrastructure, and deployment

Top 1%

9.5DataRank

Journal of the American Medical Informatics Association(2020)

co-cited

10.1093/jamia/ocaa196

Utilization of the Cancer Medications Enquiry Database (CanMED)-National Drug Codes (NDC): Assessment of Systemic Breast Cancer Treatment Patterns

Top 36%

0.535DataRank

JNCI Monographs(2020)

co-cited

10.1093/jncimonographs/lgaa002